A carregar...
Targeting the Ras pathway in pediatric hematologic malignancies
PURPOSE: Ras pathway mutations are one of the most common type of alterations in pediatric hematologic malignancies and are frequently associated with adverse outcomes. Despite ongoing efforts to use targeted treatments, there remain no food and drug administration (FDA) approved medications specifi...
Na minha lista:
| Publicado no: | Curr Opin Pediatr |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880552/ https://ncbi.nlm.nih.gov/pubmed/33394740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000981 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|